We are comparing the effects of two doses of Macitentan on blood vessel function and heart health in healthy participants. This research may help us understand how different doses impact the body.
Health conditions and diseases that the clinical trial is designed to study and treat.
Pulmonary Arterial Hypertension (PAH) is a rare but serious condition characterized by high blood pressure in the arteries that supply the lungs, which can lead to symptoms like shortness of breath, fatigue, and chest pain.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.